Author

Mélanie Grosso

Observed name: Melanie Grosso

OpenAlex ID: A5030140735

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors

2025 · Ruth Plummer, Mikael H. Sodergren, et al. · Cell Reports Medicine · 16

Pre- and Post-Treatment Immune Contexture Correlates with Long Term Response in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel (axi-cel)

2023 · Mike Mattie, Melanie Grosso, et al. · Blood · 2

Abstract LB192: MTL-CEBPA in combination with pembrolizumab converts an immune desert to an inflamed TME in solid tumors resistant to checkpoint blockade

2023 · Ruth Plummer, Mikael Sodergren, et al. · Cancer Research · 1

Works count: 3

Citation count: 19

H-index: 2

I10-index: 1